Literature DB >> 27052013

Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease.

William N Hannah1, Stephen A Harrison2.   

Abstract

NAFLD is the leading cause of chronic liver disease in the Western world with an estimated prevalence of 20-30 %. Lifestyle interventions targeted at weight loss through dietary interventions and exercise are the most effective treatment, but only a minority of patients are able to achieve and sustain the necessary intervention targets. Weight loss of 3-5 % has been associated with a reduction of hepatic steatosis while weight loss of ≥5-7 % has correlated with resolution of NASH in some studies. Greater reductions in weight loss (≥10 %) may improve hepatic fibrosis. In the absence of weight loss, no specific diet has demonstrated superiority. Physical activity can improve hepatic steatosis and metabolic indices even without weight loss. Diet coupled with exercise can produce significant weight loss and may improve histologic components of the NAFLD activity score. While formal guidelines for diet and exercise in NAFLD are lacking, adherence to diet and exercise recommendations similar to those from the American Diabetes Association for diabetic care seems reasonable. Dietary supplementation with vitamin E in non-diabetics with biopsy-proven NASH has been shown to improve NAFLD activity score. The role for other macronutrients, micronutrients, antioxidants, and probiotics in the treatment of NAFLD remains limited.

Entities:  

Keywords:  Exercise; Nonalcoholic fatty liver disease; Probiotics; Weight loss

Mesh:

Year:  2016        PMID: 27052013     DOI: 10.1007/s10620-016-4153-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  73 in total

1.  Association of Coffee Consumption With Overall and Cause-Specific Mortality in a Large US Prospective Cohort Study.

Authors:  Erikka Loftfield; Neal D Freedman; Barry I Graubard; Kristin A Guertin; Amanda Black; Wen-Yi Huang; Fatma M Shebl; Susan T Mayne; Rashmi Sinha
Journal:  Am J Epidemiol       Date:  2015-11-27       Impact factor: 4.897

2.  Sedentary lifestyle and antecedents of cardiovascular disease in young adults.

Authors:  Jonathan M McGavock; Todd J Anderson; Richard Z Lewanczuk
Journal:  Am J Hypertens       Date:  2006-07       Impact factor: 2.689

3.  Primary prevention of cardiovascular disease with a Mediterranean diet.

Authors:  Ramón Estruch; Emilio Ros; Jordi Salas-Salvadó; Maria-Isabel Covas; Dolores Corella; Fernando Arós; Enrique Gómez-Gracia; Valentina Ruiz-Gutiérrez; Miquel Fiol; José Lapetra; Rosa Maria Lamuela-Raventos; Lluís Serra-Majem; Xavier Pintó; Josep Basora; Miguel Angel Muñoz; José V Sorlí; José Alfredo Martínez; Miguel Angel Martínez-González
Journal:  N Engl J Med       Date:  2013-02-25       Impact factor: 91.245

4.  Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study.

Authors:  Tannaz Eslamparast; Hossein Poustchi; Farhad Zamani; Maryam Sharafkhah; Reza Malekzadeh; Azita Hekmatdoost
Journal:  Am J Clin Nutr       Date:  2014-01-08       Impact factor: 7.045

5.  The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study.

Authors:  David Tendler; Sauyu Lin; William S Yancy; John Mavropoulos; Pam Sylvestre; Don C Rockey; Eric C Westman
Journal:  Dig Dis Sci       Date:  2007-01-12       Impact factor: 3.199

6.  Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.

Authors:  Hellan Kang; Joel K Greenson; Jason T Omo; Cewin Chao; Debra Peterman; Lilian Anderson; Laura Foess-Wood; Mary A Sherbondy; Hari S Conjeevaram
Journal:  Am J Gastroenterol       Date:  2006-10       Impact factor: 10.864

7.  Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.

Authors:  Nathalie C Leite; Cristiane A Villela-Nogueira; Vera L N Pannain; Adriana C Bottino; Guilherme F M Rezende; Claudia R L Cardoso; Gil F Salles
Journal:  Liver Int       Date:  2011-02-20       Impact factor: 5.828

Review 8.  Metabolic effects of fructose and the worldwide increase in obesity.

Authors:  Luc Tappy; Kim-Anne Lê
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

9.  Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study.

Authors:  Vincent Wai-Sun Wong; Grace Lai-Hung Won; Angel Mei-Ling Chim; Winnie Chiu-Wing Chu; David Ka-Wai Yeung; Kevin Chi-To Li; Henry Lik-Yuen Chan
Journal:  Ann Hepatol       Date:  2013 Mar-Apr       Impact factor: 2.400

10.  Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients.

Authors:  Lutgarda Bozzetto; Anna Prinster; Giovanni Annuzzi; Lucia Costagliola; Anna Mangione; Alessandra Vitelli; Raffaella Mazzarella; Margaret Longobardo; Marcello Mancini; Carlo Vigorito; Gabriele Riccardi; Angela A Rivellese
Journal:  Diabetes Care       Date:  2012-07       Impact factor: 19.112

View more
  31 in total

1.  Cell-free DNA methylation as liquid biopsy for the assessment of fibrosis in patients with nonalcoholic steatohepatitis: a gap between innovation and implementation.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

2.  Overview of Current and Emerging Therapeutic Approaches to Nonalcoholic Steatohepatitis.

Authors:  Stephen A Harrison
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-06

3.  Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Zobair M Younossi; Rohit Loomba; Mary E Rinella; Elisabetta Bugianesi; Giulio Marchesini; Brent A Neuschwander-Tetri; Lawrence Serfaty; Francesco Negro; Stephen H Caldwell; Vlad Ratziu; Kathleen E Corey; Scott L Friedman; Manal F Abdelmalek; Stephen A Harrison; Arun J Sanyal; Joel E Lavine; Philippe Mathurin; Michael R Charlton; Naga P Chalasani; Quentin M Anstee; Kris V Kowdley; Jacob George; Zachary D Goodman; Keith Lindor
Journal:  Hepatology       Date:  2018-07       Impact factor: 17.425

Review 4.  Future of Treatment for Nonalcoholic Steatohepatitis: Can the Use of Safe, Evidence-Based, Clinically Proven Supplements Provide the Answer to the Unmet Need?

Authors:  Yaron Ilan
Journal:  Dig Dis Sci       Date:  2018-04-20       Impact factor: 3.199

5.  Vertical Sleeve Gastrectomy Attenuates the Progression of Non-Alcoholic Steatohepatitis in Mice on a High-Fat High-Cholesterol Diet.

Authors:  Emily Whang; Yuan Liu; Shoichi Kageyama; Shih Lung Woo; Jieping Yang; Rupo Lee; Zhaoping Li; Haofeng Ji; Yijun Chen; Jerzy W Kupiec-Weglinski
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

Review 6.  Prevention of Hepatocellular Carcinoma.

Authors:  Kerstin Schütte; Fathi Balbisi; Peter Malfertheiner
Journal:  Gastrointest Tumors       Date:  2016-08-18

7.  Identification of Key Biomarkers and Immune Infiltration in Liver Tissue after Bariatric Surgery.

Authors:  Xiaoyan Zhang; Jingxin Li; Tiancai Liu; Min Zhao; Baozhu Liang; Hong Chen; Zhen Zhang
Journal:  Dis Markers       Date:  2022-06-25       Impact factor: 3.464

8.  Plant-derived oleanolic acid ameliorates markers associated with non-alcoholic fatty liver disease in a diet-induced pre-diabetes rat model.

Authors:  Mlindeli Gamede; Lindokuhle Mabuza; Phikelelani Ngubane; Andile Khathi
Journal:  Diabetes Metab Syndr Obes       Date:  2019-10-01       Impact factor: 3.168

9.  Managing the Burden of Non-NASH NAFLD.

Authors:  Christopher J Danford; Jorge E Sanchez; Kathleen E Corey
Journal:  Curr Hepatol Rep       Date:  2017-10-27

10.  Explore the Mechanism of Astragalus mongholicus Bunge against Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Experimental Verification.

Authors:  Lili Fu; Zhongming Wu; Yanjun Chu; Wenbin Chen; Ling Gao; Shumin Mu; Jiajun Zhao
Journal:  Gastroenterol Res Pract       Date:  2022-04-05       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.